Mexico
Diagnostic Labs Market is anticipated to witness an impressive growth during
the forecast period, 2024-2028.This
can be ascribed to the rising prevalence of various chronic diseases among the populations
across the country.
Growing
prevalence of chronic disease such as cardiovascular disease, cancer has led to
the increase in demand for diagnostic Labs for diagnosis purposes and
monitoring treatments at different stages of the disease. According to Global
Cancer Observatory, there are around 195,499 new cases of cancer reported in
Mexico in 2020. Out of these cases 89,536 new cancer cases were reported in
males and 105,963 are new cancer cases were reported among females. Breast
cancer, cervix uteri cancer, thyroid cancer, colorectum cancer, corpus uteri
cancer was the most prevalent five types of cancer among women in the country.
In males, the most prevalent five types of cancers reported in 2020 were prostate
cancer, colorectum cancer, stomach cancer, lung cancer, and non-hodgkin
lymphoma. These statistics illustrate the requirement of regular diagnosis
and mandatory check-ups, thereby boosting the growth of Mexico Diagnostic Labs
market.
Rising
Prevalence of Cardiovascular Diseases
According
to the Global Burden of Disease statistics, in 2020-2021, Mexico reported ischemic
heart diseases as the leading cause for mortality among the population after
the COVID-19 mortality cases. In 2021, 164,461 deaths
occurred in the country due to ischemic heart disease conditions, followed by
prevalence of diabetes mellitus causing 143,020 deaths. Diseases
such as Cerebrovascular disease, Hypertensive diseases, Malignant neoplasms,
Digestive diseases and Respiratory infections are highly prevalent in Mexico
and thereby are creating a higher demand for the diagnostic labs required for
diagnosis and regular monitoring of the disease and symptoms, thus providing
the Mexico Diagnostic Labs Market a lucrative growth.
Increased
Testing for Infectious Diseases
In
Mexico Hepatitis A Virus (HAV) infection is among the leading viral hepatitis
among children of age 1-9 years, as the vaccine is yet not included in the
national immunization program (NIP) in Mexico. To confirm the
hepatitis A Virus, serological testing is performed, which further detects the
presence of Immunoglobulin M (IgM) anti-HAV in the in the convalescent phase of
the infection. Under diagnosis the IgM antibodies indicate recent infection and
IgG antibodies indicate past infection and usually persists throughout an
individual’s lifespan after infection or vaccination. The increased testing for
Hepatitis A Virus (HAV) infection is giving a boost to the Mexico diagnostic
Labs Market growth. Rising incidence of infectious diseases such as typhoid,
malaria, herpes simplex, HIV/AIDS and skin diseases is expected to raise the
demand for distinct microbiology and cytology test thereby creating a demand
for Diagnostic Labs Market growth in the country.
Rising
Number of Obesity Cases
Mexico
is an emerging country with young demographics, with a consumption of unhealthy
food and living a sedentary lifestyle, the country has reportedly observed a
larger population with increasing weight and even in overweight conditions. Approximately
75% of Mexico’s adult population is either obese or overweight, which makes the
country one of the world’s leading countries in both adult and childhood
obesity. With growing population, the unhealthy lifestyle and Obesity-prevalence
rate is also rising giving rise to various health conditions such as heart
disease, stroke, type 2 diabetes and certain types of cancer. The sedentary
lifestyle giving rise to less physical movement due to the office and the new
work from home lifestyle along with no physical exercise is creating severe
health worsening conditions such as arthritis, hypertension, heart disease,
stroke, cancer, and diabetes thereby creating an essential requirement for the
diagnostic and testing labs for regular check-ups and monitoring thereby
driving the Mexico Diagnostic Labs market growth.
Well
Established Healthcare Infrastructure
The
availability of significant number of diagnostic labs in distinct regions of
Mexico has aided the healthcare system in Mexico. Mexico ranks second in the
Americas on account of number of accredited labs. The number of accredited
labs in Mexico were 18 on count till 2005 which rose to a higher count of 81 in
2015. Mexico has a social security system which provides health insurance
to all the formal workers
and their families. For people outside the formal workforce, the public
insurance scheme Seguro Popular provided insurance coverage for millions of the
low-income Mexicans until its current replacement by Instituto de Salud para El
Bienestar in January 2020.The new system Instituto de Salud para El Bienestar
is subjected to aim to decentralized and integrate distinct public healthcare
institutions to provide free healthcare to all the Mexicans in a more efficient
and integrated manner and thus were providing more routinely healthcare and
diagnostic facilities to the country people thereby boosting the Mexico
Diagnostic Labs Market.
Download Free Sample Report
Market
Segmentation
Mexico
Diagnostic Labs Market is segmented into Provider Type, test type, end users, and
region. Based on product type, the market can be segmented into Hospital Based
Diagnostic Labs, Diagnostic Chains and Stand-Alone Diagnostic Labs. Depending
on the Test type, the market can be segmented into Pathology and Radiology.
Based on end users, the market can be differentiated into Walk-ins, Referrals
and Corporate Clients.
Market Players
Laboratorio
Médico del Chopo, Estudios Clínicos Dr. T.J. Oriard SA de CV, Quest Diagnostics
Incorporated, Diagno, Salud Digna, Omicron Lab (Omnigenomics), Lans
Laboratorios de Referencia, S.A. de C.V., etc. are some of the leading players
operating in the Mexico Diagnostic Labs Market.
Attribute
|
Details
|
Base
Year
|
2022
|
Historic
Data
|
2018 – 2021
|
Estimated
Year
|
2023
|
Forecast
Period
|
2024 – 2028
|
Quantitative
Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2024-2028
|
Report
Coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
Segments
Covered
|
By Provider Type
By Test Type
By End User
By Region
|
Regional
scope
|
North,
Central Mexico, Central North, South Mexico
|
Key
companies profiled
|
Laboratorio Médico del Chopo, Estudios Clínicos Dr. T.J.
Oriard SA de CV, Quest Diagnostics Incorporated, Diagno, Salud Digna, Omicron
Lab (Omnigenomics), Lans Laboratorios de Referencia, S.A. de C.V
|
Customization
scope
|
10%
free report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
Pricing
and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
Delivery
Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/Word format on special request)
|
Report Scope:
In this report, Mexico Diagnostic Labs Market
has been segmented
into the following categories, in addition to the industry trends which have
also been detailed below:
·
Mexico
Diagnostic Labs Market, By Provider Type:
o
Hospital Based Diagnostic Labs
o
Diagnostic Chains
o
Stand
Alone Diagnostic Labs
·
Mexico
Diagnostic Labs Market, By Test Type:
o
Pathology
o
Radiology
·
Mexico
Diagnostic Labs Market, By End User:
o Walk-ins
o Referrals
o Corporate Clients
·
Mexico Diagnostic Labs
Market, By Region
o North
o Central Mexico
o Central North
o South Mexico
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in the Mexico Diagnostic Labs Market.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to
five).
Mexico Diagnostic Labs Market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]